Investigation on cardiovascular risk prediction using physiological parameters

Wan-Hua Lin1, Heye Zhang1, Yuan-Ting Zhang2

  • 1SIAT-Institute of Biomedical and Health Engineering, Chinese Academy of Sciences, Shenzhen 518055, China ; The CAS Laboratory for Health Informatics, Shenzhen Institutes of Advanced Technology, Shenzhen 518055, China.

Insights

Predicting cardiovascular disease (CVD) risk early is crucial. Key physiological measures like blood pressure and electrocardiograms, combined with new technologies, can improve CVD event prediction and prevention.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Preventive Medicine

Background:

  • Cardiovascular disease (CVD) remains the leading global cause of mortality.
  • Early prediction of CVD is essential for effective prevention and treatment strategies.
  • Improving existing CVD risk prediction models necessitates incorporating novel, independent prognostic factors.

Purpose of the Study:

  • To investigate physiological parameters as risk factors for predicting cardiovascular events.
  • To summarize current medical devices for physiological testing.
  • To discuss the implications of these advancements for future CVD prevention and treatment.

Main Methods:

  • Analysis of physiological parameters including blood pressure, electrocardiogram, arterial stiffness, ankle-brachial blood pressure index (ABI), and blood glucose.
  • Review of current medical devices for physiological measurements.
  • Exploration of unobtrusive, wireless, and computer modeling technologies for real-time data assessment.

Main Results:

  • Blood pressure, electrocardiogram, arterial stiffness, ABI, and blood glucose measurements provide valuable information for predicting both long-term and near-term cardiovascular risk.
  • Existing predictive values require further validation with more comprehensive measures.
  • Advancements in technology enable remote, real-time, out-of-hospital physiological monitoring.

Conclusions:

  • Physiological parameters are vital for cardiovascular risk prediction.
  • Technological integration, including unobtrusive sensing and data fusion, holds promise for personalized, real-time CVD risk assessment.
  • Further validation is needed to fully leverage these measures for enhanced CVD prevention and management.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
1.3K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
5.4K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
757